Impact of Luteinizing Hormone Receptor Activation on Ovarian Cancer Cells
Author Information
Author(s): Cui Juan, Miner Brooke M, Eldredge Joanna B, Warrenfeltz Susanne W, Dam Phuongan, Xu Ying, Puett David
Primary Institution: University of Georgia
Hypothesis
Can transcriptomic profiling elucidate the cellular pathways that are operative in response to LH activation of LHR in ovarian carcinoma cells?
Conclusion
The study reveals extensive transcriptomic changes in ovarian cancer cells due to LH receptor activation, suggesting new cancer therapies and potential serum markers.
Supporting Evidence
- 1,783 genes were differentially expressed in response to LH treatment.
- Five significant gene families were enriched, including growth factors and translation regulators.
- Over 100 proteins were identified as potential serum markers for ovarian cancer.
Takeaway
This study looked at how a hormone called luteinizing hormone affects cancer cells in the ovaries, finding that it changes many genes and could help in developing new treatments.
Methodology
The human ovarian cancer cell line SKOV-3 was stably transfected to express functional LHR and incubated with LH for various periods, followed by transcriptomic profiling using microarray and qRT-PCR analyses.
Potential Biases
Potential bias due to the use of a single cell line and the specific conditions under which experiments were conducted.
Limitations
The study primarily focuses on a single cell line, which may not fully represent the complexity of ovarian cancer.
Participant Demographics
Human ovarian cancer cell line SKOV-3, with no specific demographic data provided.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website